140 related articles for article (PubMed ID: 23050314)
1. The use of Pluronic lecithin organogels in the transdermal delivery of drugs.
Bramwell BL; Williams LA
Int J Pharm Compd; 2012; 16(1):62-3. PubMed ID: 23050314
[TBL] [Abstract][Full Text] [Related]
2. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
Woodall R; Arnold JJ; McKay D; Asbill CS
Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
Boddu SH; Bonam SP; Wei Y; Alexander K
Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
[TBL] [Abstract][Full Text] [Related]
4. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs.
Almeida H; Amaral MH; Lobão P; Lobo JM
J Pharm Pharm Sci; 2012; 15(4):592-605. PubMed ID: 23106961
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
6. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
Mohammed AM; Faisal W; Saleh KI; Osman SK
Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
[TBL] [Abstract][Full Text] [Related]
7. Propolis organogel as a novel topical delivery system for treating wounds.
Balata G; El Nahas HM; Radwan S
Drug Deliv; 2014 Feb; 21(1):55-61. PubMed ID: 24295500
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel.
Zhang Q; Song Y; Page SW; Garg S
J Pharm Sci; 2018 Feb; 107(2):587-594. PubMed ID: 28935590
[TBL] [Abstract][Full Text] [Related]
9. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
10. Optimization and evaluation of pluronic lecithin organogels as a transdermal delivery vehicle for sinomenine.
Ba W; Li Z; Wang L; Wang D; Liao W; Fan W; Wu Y; Liao F; Yu J
Pharm Dev Technol; 2016 Aug; 21(5):535-45. PubMed ID: 25757643
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles.
Główka E; Wosicka-Frąckowiak H; Hyla K; Stefanowska J; Jastrzębska K; Klapiszewski Ł; Jesionowski T; Cal K
Eur J Pharm Biopharm; 2014 Sep; 88(1):75-84. PubMed ID: 25014763
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan.
Agrawal V; Gupta V; Ramteke S; Trivedi P
AAPS PharmSciTech; 2010 Dec; 11(4):1718-25. PubMed ID: 21128126
[TBL] [Abstract][Full Text] [Related]
13. Organogels in Drug Delivery: A Special Emphasis on Pluronic Lecithin Organogels.
Alsaab H; Bonam SP; Bahl D; Chowdhury P; Alexander K; Boddu SH
J Pharm Pharm Sci; 2016; 19(2):252-73. PubMed ID: 27518174
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the stability of acetaminophen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J
Int J Pharm Compd; 2012; 16(5):428-30. PubMed ID: 23072202
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the stability of fluoxetine in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J
Int J Pharm Compd; 2014; 18(3):253-5. PubMed ID: 25306774
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin.
Le UM; Baltzley S; AlGhananeem A
Int J Pharm Compd; 2018; 22(6):498-503. PubMed ID: 30384350
[TBL] [Abstract][Full Text] [Related]
17. Lecithin-based nanostructured gels for skin delivery: an update on state of art and recent applications.
Elnaggar YS; El-Refaie WM; El-Massik MA; Abdallah OY
J Control Release; 2014 Apr; 180():10-24. PubMed ID: 24531009
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the stability of promethazine hydrochloride in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
Peacock GF; Sauvageot J
Int J Pharm Compd; 2014; 18(4):345-7. PubMed ID: 25474864
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
Boddu SH; Bonam SP; Jung R
Drug Dev Ind Pharm; 2015 Apr; 41(4):605-12. PubMed ID: 24517574
[TBL] [Abstract][Full Text] [Related]
20. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.
Mady FM; Essa H; El-Ammawi T; Abdelkader H; Hussein AK
Drug Des Devel Ther; 2016; 10():1101-10. PubMed ID: 27022248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
